nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ABCB1—Vismodegib—skin cancer	0.176	0.557	CbGbCtD
Estriol—ABCB1—Dactinomycin—skin cancer	0.0926	0.292	CbGbCtD
Estriol—ABCB1—Docetaxel—skin cancer	0.0478	0.151	CbGbCtD
Estriol—SHBG—hindlimb—skin cancer	0.018	0.196	CbGeAlD
Estriol—ESR2—neck—skin cancer	0.00632	0.0691	CbGeAlD
Estriol—SHBG—neck—skin cancer	0.00614	0.0671	CbGeAlD
Estriol—ESR1—blood vessel—skin cancer	0.00605	0.0661	CbGeAlD
Estriol—ESR2—connective tissue—skin cancer	0.00453	0.0495	CbGeAlD
Estriol—SHBG—connective tissue—skin cancer	0.0044	0.0481	CbGeAlD
Estriol—ESR1—neck—skin cancer	0.00433	0.0473	CbGeAlD
Estriol—ESR2—epithelium—skin cancer	0.0043	0.047	CbGeAlD
Estriol—Back pain—Vismodegib—skin cancer	0.00427	0.00722	CcSEcCtD
Estriol—Muscle spasms—Vismodegib—skin cancer	0.00424	0.00717	CcSEcCtD
Estriol—Cerebrovascular accident—Imiquimod—skin cancer	0.00394	0.00666	CcSEcCtD
Estriol—Menstruation irregular—Docetaxel—skin cancer	0.00383	0.00647	CcSEcCtD
Estriol—Migraine—Imiquimod—skin cancer	0.0038	0.00642	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00373	0.00631	CcSEcCtD
Estriol—Breast pain—Temozolomide—skin cancer	0.00365	0.00618	CcSEcCtD
Estriol—Weight decreased—Vemurafenib—skin cancer	0.00354	0.00598	CcSEcCtD
Estriol—Nervous system disorder—Vismodegib—skin cancer	0.00353	0.00597	CcSEcCtD
Estriol—Skin disorder—Vismodegib—skin cancer	0.0035	0.00591	CcSEcCtD
Estriol—Breast disorder—Imiquimod—skin cancer	0.00349	0.0059	CcSEcCtD
Estriol—Infestation NOS—Vemurafenib—skin cancer	0.00349	0.0059	CcSEcCtD
Estriol—Infestation—Vemurafenib—skin cancer	0.00349	0.0059	CcSEcCtD
Estriol—Polyp—Docetaxel—skin cancer	0.00349	0.00589	CcSEcCtD
Estriol—Deep vein thrombosis—Docetaxel—skin cancer	0.00349	0.00589	CcSEcCtD
Estriol—Tenderness—Fluorouracil—skin cancer	0.00337	0.00569	CcSEcCtD
Estriol—ESR2—lymphoid tissue—skin cancer	0.00331	0.0362	CbGeAlD
Estriol—ESR2—female reproductive system—skin cancer	0.00319	0.0349	CbGeAlD
Estriol—Pulmonary embolism—Temozolomide—skin cancer	0.00319	0.00539	CcSEcCtD
Estriol—Vaginal inflammation—Temozolomide—skin cancer	0.00319	0.00539	CcSEcCtD
Estriol—Cyst—Docetaxel—skin cancer	0.00317	0.00536	CcSEcCtD
Estriol—Dyspepsia—Vismodegib—skin cancer	0.00317	0.00536	CcSEcCtD
Estriol—Gastrointestinal disorder—Vismodegib—skin cancer	0.00311	0.00526	CcSEcCtD
Estriol—SHBG—female reproductive system—skin cancer	0.0031	0.0339	CbGeAlD
Estriol—ESR1—connective tissue—skin cancer	0.0031	0.0339	CbGeAlD
Estriol—Oedema peripheral—Vemurafenib—skin cancer	0.00309	0.00522	CcSEcCtD
Estriol—Pain—Vismodegib—skin cancer	0.00308	0.00521	CcSEcCtD
Estriol—Connective tissue disorder—Vemurafenib—skin cancer	0.00308	0.0052	CcSEcCtD
Estriol—Vaginal infection—Temozolomide—skin cancer	0.00301	0.00509	CcSEcCtD
Estriol—Infestation—Imiquimod—skin cancer	0.00298	0.00503	CcSEcCtD
Estriol—Infestation NOS—Imiquimod—skin cancer	0.00298	0.00503	CcSEcCtD
Estriol—Depression—Imiquimod—skin cancer	0.00297	0.00502	CcSEcCtD
Estriol—Erythema multiforme—Vemurafenib—skin cancer	0.00296	0.00501	CcSEcCtD
Estriol—Gastrointestinal pain—Vismodegib—skin cancer	0.00295	0.00498	CcSEcCtD
Estriol—ESR1—epithelium—skin cancer	0.00294	0.0322	CbGeAlD
Estriol—Acute coronary syndrome—Imiquimod—skin cancer	0.00293	0.00496	CcSEcCtD
Estriol—Eye disorder—Vemurafenib—skin cancer	0.00293	0.00495	CcSEcCtD
Estriol—Myocardial infarction—Imiquimod—skin cancer	0.00292	0.00493	CcSEcCtD
Estriol—Cardiac disorder—Vemurafenib—skin cancer	0.00291	0.00491	CcSEcCtD
Estriol—Neoplasm—Temozolomide—skin cancer	0.00288	0.00487	CcSEcCtD
Estriol—Abdominal pain—Vismodegib—skin cancer	0.00285	0.00481	CcSEcCtD
Estriol—Angiopathy—Vemurafenib—skin cancer	0.00284	0.0048	CcSEcCtD
Estriol—Hepatobiliary disease—Imiquimod—skin cancer	0.00282	0.00476	CcSEcCtD
Estriol—Cerebrovascular accident—Bleomycin—skin cancer	0.0028	0.00473	CcSEcCtD
Estriol—Abnormal vision—Temozolomide—skin cancer	0.00278	0.0047	CcSEcCtD
Estriol—Alopecia—Vemurafenib—skin cancer	0.00277	0.00468	CcSEcCtD
Estriol—Malnutrition—Vemurafenib—skin cancer	0.00273	0.00461	CcSEcCtD
Estriol—Thrombophlebitis—Temozolomide—skin cancer	0.00267	0.00452	CcSEcCtD
Estriol—ESR2—head—skin cancer	0.00267	0.0292	CbGeAlD
Estriol—Back pain—Vemurafenib—skin cancer	0.00264	0.00446	CcSEcCtD
Estriol—Connective tissue disorder—Imiquimod—skin cancer	0.00263	0.00444	CcSEcCtD
Estriol—Vascular purpura—Temozolomide—skin cancer	0.00259	0.00437	CcSEcCtD
Estriol—Visual impairment—Imiquimod—skin cancer	0.00258	0.00435	CcSEcCtD
Estriol—Pruritus—Vismodegib—skin cancer	0.00255	0.00431	CcSEcCtD
Estriol—Erythema multiforme—Imiquimod—skin cancer	0.00253	0.00427	CcSEcCtD
Estriol—Eye disorder—Imiquimod—skin cancer	0.0025	0.00422	CcSEcCtD
Estriol—Diarrhoea—Vismodegib—skin cancer	0.00247	0.00417	CcSEcCtD
Estriol—Thrombophlebitis—Fluorouracil—skin cancer	0.00246	0.00416	CcSEcCtD
Estriol—Angiopathy—Imiquimod—skin cancer	0.00242	0.0041	CcSEcCtD
Estriol—Immune system disorder—Imiquimod—skin cancer	0.00241	0.00408	CcSEcCtD
Estriol—ABCB1—blood vessel—skin cancer	0.00239	0.0261	CbGeAlD
Estriol—Alopecia—Imiquimod—skin cancer	0.00236	0.00399	CcSEcCtD
Estriol—Bone disorder—Docetaxel—skin cancer	0.00235	0.00397	CcSEcCtD
Estriol—Mental disorder—Imiquimod—skin cancer	0.00234	0.00396	CcSEcCtD
Estriol—Malnutrition—Imiquimod—skin cancer	0.00233	0.00393	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00231	0.0039	CcSEcCtD
Estriol—Vomiting—Vismodegib—skin cancer	0.00229	0.00387	CcSEcCtD
Estriol—Rash—Vismodegib—skin cancer	0.00227	0.00384	CcSEcCtD
Estriol—Dermatitis—Vismodegib—skin cancer	0.00227	0.00384	CcSEcCtD
Estriol—ESR1—lymphoid tissue—skin cancer	0.00227	0.0248	CbGeAlD
Estriol—Back pain—Imiquimod—skin cancer	0.00225	0.0038	CcSEcCtD
Estriol—Anaphylactic shock—Vemurafenib—skin cancer	0.00223	0.00376	CcSEcCtD
Estriol—Infection—Vemurafenib—skin cancer	0.00221	0.00374	CcSEcCtD
Estriol—ESR1—female reproductive system—skin cancer	0.00219	0.0239	CbGeAlD
Estriol—Nervous system disorder—Vemurafenib—skin cancer	0.00218	0.00369	CcSEcCtD
Estriol—Skin disorder—Vemurafenib—skin cancer	0.00216	0.00365	CcSEcCtD
Estriol—SLCO1A2—head—skin cancer	0.00215	0.0235	CbGeAlD
Estriol—Weight decreased—Bleomycin—skin cancer	0.00215	0.00363	CcSEcCtD
Estriol—Nausea—Vismodegib—skin cancer	0.00214	0.00362	CcSEcCtD
Estriol—Angioedema—Imiquimod—skin cancer	0.00213	0.00359	CcSEcCtD
Estriol—Pulmonary embolism—Docetaxel—skin cancer	0.00212	0.00358	CcSEcCtD
Estriol—Blood pressure increased—Docetaxel—skin cancer	0.00212	0.00358	CcSEcCtD
Estriol—Breast disorder—Temozolomide—skin cancer	0.00209	0.00353	CcSEcCtD
Estriol—Acute coronary syndrome—Bleomycin—skin cancer	0.00208	0.00352	CcSEcCtD
Estriol—Myocardial infarction—Bleomycin—skin cancer	0.00207	0.0035	CcSEcCtD
Estriol—Abdominal distension—Temozolomide—skin cancer	0.00201	0.0034	CcSEcCtD
Estriol—Fluid retention—Docetaxel—skin cancer	0.00201	0.0034	CcSEcCtD
Estriol—Hypertension—Imiquimod—skin cancer	0.00201	0.00339	CcSEcCtD
Estriol—Anxiety—Imiquimod—skin cancer	0.00197	0.00334	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00197	0.00332	CcSEcCtD
Estriol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00192	0.00325	CcSEcCtD
Estriol—Neoplasm—Docetaxel—skin cancer	0.00192	0.00324	CcSEcCtD
Estriol—Oedema—Imiquimod—skin cancer	0.0019	0.00321	CcSEcCtD
Estriol—Infection—Imiquimod—skin cancer	0.00189	0.00319	CcSEcCtD
Estriol—Shock—Imiquimod—skin cancer	0.00187	0.00316	CcSEcCtD
Estriol—ESR2—lymph node—skin cancer	0.00187	0.0204	CbGeAlD
Estriol—Nervous system disorder—Imiquimod—skin cancer	0.00186	0.00315	CcSEcCtD
Estriol—Skin disorder—Imiquimod—skin cancer	0.00184	0.00312	CcSEcCtD
Estriol—ESR1—head—skin cancer	0.00183	0.02	CbGeAlD
Estriol—Weight increased—Temozolomide—skin cancer	0.00182	0.00308	CcSEcCtD
Estriol—Weight decreased—Temozolomide—skin cancer	0.00181	0.00306	CcSEcCtD
Estriol—Infestation NOS—Temozolomide—skin cancer	0.00178	0.00301	CcSEcCtD
Estriol—Infestation—Temozolomide—skin cancer	0.00178	0.00301	CcSEcCtD
Estriol—Depression—Temozolomide—skin cancer	0.00178	0.00301	CcSEcCtD
Estriol—Thrombophlebitis—Docetaxel—skin cancer	0.00178	0.00301	CcSEcCtD
Estriol—Insomnia—Imiquimod—skin cancer	0.00172	0.0029	CcSEcCtD
Estriol—Cardiac failure congestive—Docetaxel—skin cancer	0.0017	0.00287	CcSEcCtD
Estriol—Hepatobiliary disease—Temozolomide—skin cancer	0.00169	0.00285	CcSEcCtD
Estriol—Alopecia—Bleomycin—skin cancer	0.00168	0.00283	CcSEcCtD
Estriol—Erythema multiforme—Dactinomycin—skin cancer	0.00167	0.00283	CcSEcCtD
Estriol—Dyspepsia—Imiquimod—skin cancer	0.00167	0.00282	CcSEcCtD
Estriol—Infestation NOS—Fluorouracil—skin cancer	0.00164	0.00278	CcSEcCtD
Estriol—Infestation—Fluorouracil—skin cancer	0.00164	0.00278	CcSEcCtD
Estriol—Hypersensitivity—Vemurafenib—skin cancer	0.00164	0.00277	CcSEcCtD
Estriol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00164	0.00277	CcSEcCtD
Estriol—Visual disturbance—Docetaxel—skin cancer	0.00162	0.00275	CcSEcCtD
Estriol—Pain—Imiquimod—skin cancer	0.00162	0.00274	CcSEcCtD
Estriol—Acute coronary syndrome—Fluorouracil—skin cancer	0.00162	0.00274	CcSEcCtD
Estriol—Myocardial infarction—Fluorouracil—skin cancer	0.00161	0.00272	CcSEcCtD
Estriol—Oedema peripheral—Temozolomide—skin cancer	0.00158	0.00267	CcSEcCtD
Estriol—Pruritus—Vemurafenib—skin cancer	0.00157	0.00266	CcSEcCtD
Estriol—Connective tissue disorder—Temozolomide—skin cancer	0.00157	0.00266	CcSEcCtD
Estriol—Alopecia—Dactinomycin—skin cancer	0.00156	0.00264	CcSEcCtD
Estriol—Gastrointestinal pain—Imiquimod—skin cancer	0.00155	0.00262	CcSEcCtD
Estriol—Visual impairment—Temozolomide—skin cancer	0.00154	0.00261	CcSEcCtD
Estriol—Diarrhoea—Vemurafenib—skin cancer	0.00152	0.00257	CcSEcCtD
Estriol—Migraine—Docetaxel—skin cancer	0.00152	0.00256	CcSEcCtD
Estriol—Erythema multiforme—Temozolomide—skin cancer	0.00151	0.00256	CcSEcCtD
Estriol—Urticaria—Imiquimod—skin cancer	0.00151	0.00255	CcSEcCtD
Estriol—Abdominal pain—Imiquimod—skin cancer	0.0015	0.00254	CcSEcCtD
Estriol—Eye disorder—Temozolomide—skin cancer	0.0015	0.00253	CcSEcCtD
Estriol—Cardiac disorder—Temozolomide—skin cancer	0.00149	0.00251	CcSEcCtD
Estriol—Dizziness—Vemurafenib—skin cancer	0.00147	0.00249	CcSEcCtD
Estriol—Angiopathy—Temozolomide—skin cancer	0.00145	0.00246	CcSEcCtD
Estriol—Immune system disorder—Temozolomide—skin cancer	0.00145	0.00244	CcSEcCtD
Estriol—Vomiting—Vemurafenib—skin cancer	0.00142	0.00239	CcSEcCtD
Estriol—Alopecia—Temozolomide—skin cancer	0.00142	0.00239	CcSEcCtD
Estriol—Rash—Vemurafenib—skin cancer	0.0014	0.00237	CcSEcCtD
Estriol—Mental disorder—Temozolomide—skin cancer	0.0014	0.00237	CcSEcCtD
Estriol—Dermatitis—Vemurafenib—skin cancer	0.0014	0.00237	CcSEcCtD
Estriol—Hypersensitivity—Imiquimod—skin cancer	0.0014	0.00236	CcSEcCtD
Estriol—Headache—Vemurafenib—skin cancer	0.00139	0.00236	CcSEcCtD
Estriol—Malnutrition—Temozolomide—skin cancer	0.00139	0.00236	CcSEcCtD
Estriol—Breast disorder—Docetaxel—skin cancer	0.00139	0.00235	CcSEcCtD
Estriol—Oedema—Bleomycin—skin cancer	0.00135	0.00228	CcSEcCtD
Estriol—Anaphylactic shock—Bleomycin—skin cancer	0.00135	0.00228	CcSEcCtD
Estriol—Back pain—Temozolomide—skin cancer	0.00135	0.00228	CcSEcCtD
Estriol—Pruritus—Imiquimod—skin cancer	0.00134	0.00227	CcSEcCtD
Estriol—Infection—Bleomycin—skin cancer	0.00134	0.00226	CcSEcCtD
Estriol—Nausea—Vemurafenib—skin cancer	0.00132	0.00223	CcSEcCtD
Estriol—Alopecia—Fluorouracil—skin cancer	0.0013	0.0022	CcSEcCtD
Estriol—Diarrhoea—Imiquimod—skin cancer	0.0013	0.0022	CcSEcCtD
Estriol—ESR1—lymph node—skin cancer	0.00128	0.014	CbGeAlD
Estriol—Angioedema—Temozolomide—skin cancer	0.00127	0.00215	CcSEcCtD
Estriol—Oedema—Dactinomycin—skin cancer	0.00126	0.00213	CcSEcCtD
Estriol—Dizziness—Imiquimod—skin cancer	0.00126	0.00212	CcSEcCtD
Estriol—Infection—Dactinomycin—skin cancer	0.00125	0.00211	CcSEcCtD
Estriol—Weight increased—Docetaxel—skin cancer	0.00121	0.00205	CcSEcCtD
Estriol—Vomiting—Imiquimod—skin cancer	0.00121	0.00204	CcSEcCtD
Estriol—Weight decreased—Docetaxel—skin cancer	0.0012	0.00203	CcSEcCtD
Estriol—Hypertension—Temozolomide—skin cancer	0.0012	0.00203	CcSEcCtD
Estriol—Rash—Imiquimod—skin cancer	0.0012	0.00202	CcSEcCtD
Estriol—Dermatitis—Imiquimod—skin cancer	0.0012	0.00202	CcSEcCtD
Estriol—Headache—Imiquimod—skin cancer	0.00119	0.00201	CcSEcCtD
Estriol—Infestation NOS—Docetaxel—skin cancer	0.00119	0.002	CcSEcCtD
Estriol—Infestation—Docetaxel—skin cancer	0.00119	0.002	CcSEcCtD
Estriol—Anxiety—Temozolomide—skin cancer	0.00118	0.002	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00118	0.00199	CcSEcCtD
Estriol—Acute coronary syndrome—Docetaxel—skin cancer	0.00117	0.00198	CcSEcCtD
Estriol—Myocardial infarction—Docetaxel—skin cancer	0.00116	0.00197	CcSEcCtD
Estriol—ABCB1—epithelium—skin cancer	0.00116	0.0127	CbGeAlD
Estriol—Pain—Bleomycin—skin cancer	0.00115	0.00195	CcSEcCtD
Estriol—Anaphylactic shock—Temozolomide—skin cancer	0.00114	0.00192	CcSEcCtD
Estriol—Oedema—Temozolomide—skin cancer	0.00114	0.00192	CcSEcCtD
Estriol—Infection—Temozolomide—skin cancer	0.00113	0.00191	CcSEcCtD
Estriol—Nausea—Imiquimod—skin cancer	0.00113	0.00191	CcSEcCtD
Estriol—Hepatobiliary disease—Docetaxel—skin cancer	0.00112	0.0019	CcSEcCtD
Estriol—Nervous system disorder—Temozolomide—skin cancer	0.00112	0.00189	CcSEcCtD
Estriol—Skin disorder—Temozolomide—skin cancer	0.00111	0.00187	CcSEcCtD
Estriol—Pain—Dactinomycin—skin cancer	0.00108	0.00182	CcSEcCtD
Estriol—Urticaria—Bleomycin—skin cancer	0.00107	0.00181	CcSEcCtD
Estriol—Oedema peripheral—Docetaxel—skin cancer	0.00105	0.00177	CcSEcCtD
Estriol—Oedema—Fluorouracil—skin cancer	0.00105	0.00177	CcSEcCtD
Estriol—Anaphylactic shock—Fluorouracil—skin cancer	0.00105	0.00177	CcSEcCtD
Estriol—Connective tissue disorder—Docetaxel—skin cancer	0.00105	0.00177	CcSEcCtD
Estriol—Infection—Fluorouracil—skin cancer	0.00104	0.00176	CcSEcCtD
Estriol—Insomnia—Temozolomide—skin cancer	0.00103	0.00174	CcSEcCtD
Estriol—Gastrointestinal pain—Dactinomycin—skin cancer	0.00103	0.00174	CcSEcCtD
Estriol—Nervous system disorder—Fluorouracil—skin cancer	0.00103	0.00174	CcSEcCtD
Estriol—Visual impairment—Docetaxel—skin cancer	0.00103	0.00173	CcSEcCtD
Estriol—ABCB1—mammalian vulva—skin cancer	0.00101	0.011	CbGeAlD
Estriol—Erythema multiforme—Docetaxel—skin cancer	0.00101	0.0017	CcSEcCtD
Estriol—Dyspepsia—Temozolomide—skin cancer	0.001	0.00169	CcSEcCtD
Estriol—Eye disorder—Docetaxel—skin cancer	0.000995	0.00168	CcSEcCtD
Estriol—Abdominal pain—Dactinomycin—skin cancer	0.000994	0.00168	CcSEcCtD
Estriol—Hypersensitivity—Bleomycin—skin cancer	0.000994	0.00168	CcSEcCtD
Estriol—Cardiac disorder—Docetaxel—skin cancer	0.000988	0.00167	CcSEcCtD
Estriol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000982	0.00166	CcSEcCtD
Estriol—Pain—Temozolomide—skin cancer	0.000973	0.00164	CcSEcCtD
Estriol—Angiopathy—Docetaxel—skin cancer	0.000966	0.00163	CcSEcCtD
Estriol—Immune system disorder—Docetaxel—skin cancer	0.000962	0.00163	CcSEcCtD
Estriol—Pruritus—Bleomycin—skin cancer	0.000954	0.00161	CcSEcCtD
Estriol—Insomnia—Fluorouracil—skin cancer	0.000948	0.0016	CcSEcCtD
Estriol—Alopecia—Docetaxel—skin cancer	0.000941	0.00159	CcSEcCtD
Estriol—Mental disorder—Docetaxel—skin cancer	0.000933	0.00158	CcSEcCtD
Estriol—Gastrointestinal pain—Temozolomide—skin cancer	0.00093	0.00157	CcSEcCtD
Estriol—Malnutrition—Docetaxel—skin cancer	0.000927	0.00157	CcSEcCtD
Estriol—Hypersensitivity—Dactinomycin—skin cancer	0.000927	0.00157	CcSEcCtD
Estriol—Dyspepsia—Fluorouracil—skin cancer	0.000923	0.00156	CcSEcCtD
Estriol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000905	0.00153	CcSEcCtD
Estriol—Urticaria—Temozolomide—skin cancer	0.000904	0.00153	CcSEcCtD
Estriol—Abdominal pain—Temozolomide—skin cancer	0.000899	0.00152	CcSEcCtD
Estriol—Back pain—Docetaxel—skin cancer	0.000897	0.00152	CcSEcCtD
Estriol—Pain—Fluorouracil—skin cancer	0.000896	0.00151	CcSEcCtD
Estriol—ABCB1—lymphoid tissue—skin cancer	0.000895	0.00979	CbGeAlD
Estriol—Muscle spasms—Docetaxel—skin cancer	0.000891	0.00151	CcSEcCtD
Estriol—ABCB1—female reproductive system—skin cancer	0.000863	0.00944	CbGeAlD
Estriol—Diarrhoea—Dactinomycin—skin cancer	0.000861	0.00145	CcSEcCtD
Estriol—Vomiting—Bleomycin—skin cancer	0.000858	0.00145	CcSEcCtD
Estriol—Rash—Bleomycin—skin cancer	0.00085	0.00144	CcSEcCtD
Estriol—Dermatitis—Bleomycin—skin cancer	0.00085	0.00144	CcSEcCtD
Estriol—Hypersensitivity—Temozolomide—skin cancer	0.000838	0.00142	CcSEcCtD
Estriol—Urticaria—Fluorouracil—skin cancer	0.000833	0.00141	CcSEcCtD
Estriol—Pruritus—Temozolomide—skin cancer	0.000805	0.00136	CcSEcCtD
Estriol—Nausea—Bleomycin—skin cancer	0.000801	0.00135	CcSEcCtD
Estriol—Hypertension—Docetaxel—skin cancer	0.0008	0.00135	CcSEcCtD
Estriol—Vomiting—Dactinomycin—skin cancer	0.0008	0.00135	CcSEcCtD
Estriol—Rash—Dactinomycin—skin cancer	0.000793	0.00134	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000784	0.00132	CcSEcCtD
Estriol—Diarrhoea—Temozolomide—skin cancer	0.000778	0.00132	CcSEcCtD
Estriol—Hypersensitivity—Fluorouracil—skin cancer	0.000772	0.00131	CcSEcCtD
Estriol—Anaphylactic shock—Docetaxel—skin cancer	0.000757	0.00128	CcSEcCtD
Estriol—Oedema—Docetaxel—skin cancer	0.000757	0.00128	CcSEcCtD
Estriol—Dizziness—Temozolomide—skin cancer	0.000752	0.00127	CcSEcCtD
Estriol—Infection—Docetaxel—skin cancer	0.000752	0.00127	CcSEcCtD
Estriol—Nausea—Dactinomycin—skin cancer	0.000747	0.00126	CcSEcCtD
Estriol—Shock—Docetaxel—skin cancer	0.000744	0.00126	CcSEcCtD
Estriol—Nervous system disorder—Docetaxel—skin cancer	0.000742	0.00125	CcSEcCtD
Estriol—Pruritus—Fluorouracil—skin cancer	0.000742	0.00125	CcSEcCtD
Estriol—Skin disorder—Docetaxel—skin cancer	0.000735	0.00124	CcSEcCtD
Estriol—Vomiting—Temozolomide—skin cancer	0.000723	0.00122	CcSEcCtD
Estriol—ABCB1—head—skin cancer	0.000721	0.00789	CbGeAlD
Estriol—Rash—Temozolomide—skin cancer	0.000717	0.00121	CcSEcCtD
Estriol—Diarrhoea—Fluorouracil—skin cancer	0.000717	0.00121	CcSEcCtD
Estriol—Dermatitis—Temozolomide—skin cancer	0.000717	0.00121	CcSEcCtD
Estriol—Headache—Temozolomide—skin cancer	0.000713	0.0012	CcSEcCtD
Estriol—Dizziness—Fluorouracil—skin cancer	0.000693	0.00117	CcSEcCtD
Estriol—Insomnia—Docetaxel—skin cancer	0.000684	0.00116	CcSEcCtD
Estriol—Nausea—Temozolomide—skin cancer	0.000676	0.00114	CcSEcCtD
Estriol—Vomiting—Fluorouracil—skin cancer	0.000666	0.00113	CcSEcCtD
Estriol—Dyspepsia—Docetaxel—skin cancer	0.000666	0.00113	CcSEcCtD
Estriol—Rash—Fluorouracil—skin cancer	0.000661	0.00112	CcSEcCtD
Estriol—Dermatitis—Fluorouracil—skin cancer	0.00066	0.00112	CcSEcCtD
Estriol—Headache—Fluorouracil—skin cancer	0.000657	0.00111	CcSEcCtD
Estriol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000653	0.0011	CcSEcCtD
Estriol—Pain—Docetaxel—skin cancer	0.000647	0.00109	CcSEcCtD
Estriol—Nausea—Fluorouracil—skin cancer	0.000623	0.00105	CcSEcCtD
Estriol—Gastrointestinal pain—Docetaxel—skin cancer	0.000619	0.00105	CcSEcCtD
Estriol—Abdominal pain—Docetaxel—skin cancer	0.000598	0.00101	CcSEcCtD
Estriol—Hypersensitivity—Docetaxel—skin cancer	0.000557	0.000942	CcSEcCtD
Estriol—Pruritus—Docetaxel—skin cancer	0.000535	0.000905	CcSEcCtD
Estriol—Diarrhoea—Docetaxel—skin cancer	0.000518	0.000875	CcSEcCtD
Estriol—ABCB1—lymph node—skin cancer	0.000505	0.00552	CbGeAlD
Estriol—Dizziness—Docetaxel—skin cancer	0.0005	0.000845	CcSEcCtD
Estriol—Vomiting—Docetaxel—skin cancer	0.000481	0.000813	CcSEcCtD
Estriol—Rash—Docetaxel—skin cancer	0.000477	0.000806	CcSEcCtD
Estriol—Dermatitis—Docetaxel—skin cancer	0.000477	0.000805	CcSEcCtD
Estriol—Headache—Docetaxel—skin cancer	0.000474	0.000801	CcSEcCtD
Estriol—Nausea—Docetaxel—skin cancer	0.000449	0.000759	CcSEcCtD
